findmyKOL
Clinical trialNCT01998828TerminatedPhase 2Interventional

Safety and Efficacy of Momelotinib in Subjects With Polycythemia Vera or Essential Thrombocythemia

SponsorSierra Oncology LLC - a GSK companyEnrollment39Essential ThrombocythemiaPolycythemia Vera
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

15 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Australia
  • Facility name not stated

    Frankston, Victoria, Australia

  • Facility name not stated

    Parkville, Victoria, Australia

Canada
  • Facility name not stated

    Vancouver, British Columbia, Canada

  • Facility name not stated

    Toronto, Ontario, Canada

  • Facility name not stated

    Montreal, Quebec, Canada

France
  • Facility name not stated

    La Tronche, France

  • Facility name not stated

    Nantes, France

  • Facility name not stated

    Paris, France

Germany
  • Facility name not stated

    Dresden, Germany

  • Facility name not stated

    Minden, Germany

United States
  • Facility name not stated

    Scottsdale, Arizona, United States

  • Facility name not stated

    Whittier, California, United States

  • Facility name not stated

    Tupelo, Mississippi, United States

  • Facility name not stated

    St Louis, Missouri, United States

  • Facility name not stated

    Houston, Texas, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
19 Feb 2014
Primary completion
17 Mar 2015
Completion
7 May 2015
Last update posted
20 Apr 2020
Registered enrollment
39
Registry id
NCT01998828

Cross-registrations

EU-CTR / CTIS (EudraCT)2013-004105-11

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.